(1) In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis, Proc Natl Acad Sci U S A, 2018, 第 11 作者
(2) A novel BMX variant promotes tumor cell growth and migration in lung adenocarcinoma, Oncotarget, 2017, 第 11 作者
(3) YAP Suppresses Lung Squamous Cell Carcinoma Progression via Deregulation of the DNp63–GPX2 Axis and ROS Accumulation, Cancer Res., 2017, 第 11 作者
(4) Cell Division Cycle 42 plays a Cell type-Specific role in Lung Tumorigenesis., Sci Rep. , 2017, 第 11 作者
(5) Evidence, Mechanism, and Clinical Relevance of the Transdifferentiation from Lung Adenocarcinoma to Squamous Cell Carcinoma., Am J Pathol, 2017, 第 11 作者
(6) Evolution from genetics to phenotype:reinterpretation of NSCLC plasticity,heterogeneity, and drug resistance, Protein Cell., 2017, 第 11 作者
(7) Identification of TRA2B-DNAH5 fusion as a novel oncogenic driver in human lung squamous cell carcinoma., Cell Res, 2016, 第 11 作者
(8) Cetuximab-modified mesoporous silica nano-medicine specifically targets EGFR-mutant lung cancer and overcomes drug resistance., Sci Rep. , 2016, 第 11 作者
(9) Squamous Transition of Lung Adenocarcinoma and Drug Resistance, Trends Cancer, 2016, 第 11 作者
(10) LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response., Cancer Cell, 2015, 第 11 作者
(11) YAP Promotes Malignant Progression of Lkb1-Deficient Lung Adenocarcinoma through Downstream Regulation of Survivin., Cancer Res., 2015, 第 11 作者
(12) VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex., Cell Res, 2014, 第 11 作者
(13) Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma, Nat Commun, 2014, 第 11 作者
(14) A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer, Cancer Cell, 2014, 第 11 作者
(15) Integrative Genomic Analysis Reveals a High Frequency of LKB1 Genetic Alteration in Chinese Lung Adenocarcinomas., J Thorac Oncol, 2014, 第 11 作者
(16) Two co-existing germline mutations P53 V157D and PMS2 R20Q promote tumorigenesis in a familial cancer syndrome, Cancer Lett, 2014, 第 11 作者
(17) Synthesis and evaluation of 2-anilinopyrimidines bearing 3-aminopropamides as potential epidermal growth factor receptor inhibitors, Eur J Med Chem, 2014, 第 11 作者
(18) Regulation of EGFR nanocluster formation by ionic protein-lipid interaction., Cell Res, 2014, 第 11 作者
(19) YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repression, Nat Commun, 2014, 第 11 作者
(20) NEDD9 promotes lung cancer metastasis through Epithelial-Mesenchymal Transition, Int J Cancer, 2014, 第 11 作者
(21) Novel Hybrids of (Phenylsulfonyl)furoxan and Anilinopyrimidine as Potent and Selective Epidermal Growth Factor Receptor Inhibitors for Intervention of Non-Small-Cell Lung Cancer., J Med Chem., 2013, 第 11 作者
(22) Nitric oxide donating anilinopyrimidines: Synthesis and biological evaluation as EGFR inhibitors., Eur J Med Chem., 2013, 第 11 作者
(23) ANCCA Protein Expression is a Novel Independent Poor Prognostic Marker in Surgically Resected Lung Adenocarcinoma., Ann Surg Oncol., 2013, 第 11 作者
(1)恶性肿瘤的细胞异质性、可塑性与精准医学 2015-10-11
(2)LKB1调控肺癌转移及腺鳞癌转分化 2015-09-24
(3)Evidence and mechanism for transdifferentiation of lung adenocarcinoma to squamous cell carcinoma 2015-06-05
(4)Transdifferentiation of lung adenocarcinoma to squamous cell carcinoma 2014-10-25
(5)Transdifferentiation of lung adenocarcinoma to squamous cell carcinoma 2014-06-26
(6)Molecular mechanisms in lung tumorigenesis 2014-05-27
(7)LKB1 in lung adenocarcinoma to squamous cell carcinoma transdifferentiation 中国细胞生物学学会2013年全国学术大会 2013-04-19